The Butcher is an comin'













The IO drugs out now are what matter. Medi has redundancies. The majority of which won't even make it to phase II clinical trials. The poster below sounds like they are from AZ trying to keep spirits up. The IO race is now setting up the next 25 years and AZ has lost. You need money to fund trials. Durvalumab will be lucky to break blockbuster by 2025. Starting up the Boulder plant for this was stupid. I'll be surprised if AZ keeps with the same plan. And it shows. They are keeping the hiring to as low of an expense as possible. They won't move hardly any of us from the MD site due to cost. And who the hell would want to work there anyway. Way too inbred.

I work for Merck and I can honestly saw that short-term we are in a fight with BMS but long term it is with AZ/Medi in the IO space. You guys have an incredible pipeline and R&D talent
 






The IO drugs out now are what matter. Medi has redundancies. The majority of which won't even make it to phase II clinical trials. The poster below sounds like they are from AZ trying to keep spirits up. The IO race is now setting up the next 25 years and AZ has lost. You need money to fund trials. Durvalumab will be lucky to break blockbuster by 2025. Starting up the Boulder plant for this was stupid. I'll be surprised if AZ keeps with the same plan. And it shows. They are keeping the hiring to as low of an expense as possible. They won't move hardly any of us from the MD site due to cost. And who the hell would want to work there anyway. Way too inbred.
Ahh, another Merck troll trying to destroy morale at Medi. Merck = one drug wonder. Merck is history once the combinations start to displace your one toxic IO asset.
 
















































Two ABMs down (Brady and Steve C) Who's next. I guess hitting your numbers with minimal support and shrinking markets isn't good enough anymore. Medimmune is dead and the leadership is "sailing the ship" into the abyss.
 






Two ABMs down (Brady and Steve C) Who's next. I guess hitting your numbers with minimal support and shrinking markets isn't good enough anymore. Medimmune is dead and the leadership is "sailing the ship" into the abyss.